Altri: third-quarter EBITDA multiplied by 2.5, driven by dissolving pulp and prices
Portuguese pulp producer Altri published on 19 November 2026 a third quarter marked by higher profitability. EBITDA reached €29.0 million, up 149.6% year on year, and the EBITDA margin rose 8.7 points to 15.8%, while sales volumes fell 8.3%.
Over nine months, the picture is different: cumulative EBITDA fell 6.9% to €64.5 million, and its margin lost 1.2 points to 11.7%, as the first quarter was hit by bad weather and storms. Net profit attributable to the group, however, rose 18.4% to €14.7 million.
Prices and mix offset the decline in sales volumes
Total revenue for the third quarter rose 11.7% year on year to €184.0 million, driven by sales of cellulose fibres (+12.7%, to €144.1 million). This increase occurred while sales volumes fell to 248.6 thousand tonnes: the group attributes this to more favourable prices and sales mix.
Market prices point in the same direction. The PIX index for European bleached hardwood kraft pulp (BHKP) averaged $1,365 per tonne, up 32% year on year, and the average price of dissolving pulp reached $902 per tonne, about 12% above its level in the third quarter of 2025.
The effect is also visible further down the income statement. Operating profit (EBIT) rose from €0.2 million to €16.6 million, a margin of 9.0%, and net profit attributable to the group reached €9.1 million, compared with a loss of €1.7 million a year earlier.
This recovery came despite a heavier financial result, at -€5.1 million versus -€2.0 million, due to higher interest paid and a less favourable contribution from currency derivatives. The tax charge also rose from €0.1 million to €2.5 million.
Dissolving pulp gains weight relative to BHKP paper pulp
Product mix weighed on this recovery: sales of dissolving pulp, mainly intended for textiles, rose 46.6% year on year to 40.2 thousand tonnes.
Conversely, BHKP sales fell 14.5% to 208.4 thousand tonnes, as the Biotek mill began gradually phasing out certain customers for this pulp.
Over nine months, dissolving pulp sales volumes rose 32.4% to 124.2 thousand tonnes, compared with a 5.9% decline for BHKP. Textiles now account for 16% of volumes sold, versus 10% in 2025, while the share of tissue (toilet and household paper) fell from 48% to 41%.
This shift also changes the geography of sales: Asia, which accounts for around 87% of global dissolving pulp demand, represents 17% of the group's volumes, compared with 12% in 2025. The full conversion of Biotek to dissolving pulp has entered its final phase and is expected to be completed during the second quarter of 2027.
Over nine months, EBITDA remains below its 2025 level
The annual cumulative figures still reflect the first quarter. At the end of June, EBITDA was down 38.5% year on year and total revenue was down 2.2%; over nine months, the latter now rises 2.1% to €548.7 million.
Compared with the second quarter, EBITDA is nearly stable (-3.4%) and its margin gains 1.1 points, despite revenue down 10.0% linked to lower summer volumes.
The cumulative financial result improves to -€10.9 million, compared with -€20.8 million, mainly thanks to exchange rate effects, which together with the operating recovery contributes to the rise in net profit.
Net debt fell to €373.3 million at the end of September, compared with €397.9 million at the end of June, thanks to a favourable change in working capital and a corporate income tax refund. It represents 4.2 times EBITDA for the last twelve months and remains above the €329.0 million at the end of 2025.
For the fourth quarter, management anticipates higher costs for electricity, natural gas and chemicals, in addition to the scheduled shutdowns of the Caima and Biotek mills carried out in October. It considers profitability in the second and third quarters “still below the levels to which we aspire”.
The group believes that “the increase in dissolving pulp sales could help consolidate this recovery trajectory during 2027”. The growth of this business thus supports the improvement in quarterly margins, while the decline in BHKP and the first quarter keep cumulative EBITDA below last year's level.